Why the study?
Does the co-administration of NSAIDs, particularly aspirin and COX-2 inhibitors, reduce warfarin control (TTR) and increase bleeding in patients on warfarin?
Does the co-administration of NSAIDs, particularly aspirin and COX-2 inhibitors, reduce warfarin control (TTR) and increase bleeding in patients on warfarin?
Co-administration of aspirin with warfarin significantly reduces time in therapeutic range and increases minor bleeding events, highlighting the need for careful monitoring when these drugs are combined.
No takes yet. Share an insight, caveat, or question.
Aspirin co-use may reduce TTR; observational data leave open whether avoiding it improves control.
Boyce et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: